Joseph S. Durgin , Neha N. Jariwala , Alain H. Rook , Juan M. Ortega-Legaspi
{"title":"γ-干扰素治疗皮肤T细胞淋巴瘤后可逆性心肌病2例报告","authors":"Joseph S. Durgin , Neha N. Jariwala , Alain H. Rook , Juan M. Ortega-Legaspi","doi":"10.1016/j.cpccr.2023.100255","DOIUrl":null,"url":null,"abstract":"<div><p>Interferons are widely expressed cytokines that possess potent anti-viral and anti-tumor activity. As therapeutic agents, interferons have proven useful in treating assorted cancers, chronic infections, and autoimmune disease. However, interferon therapy has well-known adverse effects, including flu-like symptoms, depression, triggering of autoimmune phenomena, and dose-dependent cytopenias. In this report, we describe two cases of congestive heart failure occurring after treatment with interferon-gamma (a type II interferon) for advanced cutaneous T cell lymphoma. Based on existing mechanistic studies, both the potentiation of autoimmunity and the direct cytotoxic effects of interferons on the myocardium may account for this uncommon adverse effect of interferon therapy.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reversible cardiomyopathy after interferon-gamma for cutaneous T cell lymphoma: A report of two cases\",\"authors\":\"Joseph S. Durgin , Neha N. Jariwala , Alain H. Rook , Juan M. Ortega-Legaspi\",\"doi\":\"10.1016/j.cpccr.2023.100255\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Interferons are widely expressed cytokines that possess potent anti-viral and anti-tumor activity. As therapeutic agents, interferons have proven useful in treating assorted cancers, chronic infections, and autoimmune disease. However, interferon therapy has well-known adverse effects, including flu-like symptoms, depression, triggering of autoimmune phenomena, and dose-dependent cytopenias. In this report, we describe two cases of congestive heart failure occurring after treatment with interferon-gamma (a type II interferon) for advanced cutaneous T cell lymphoma. Based on existing mechanistic studies, both the potentiation of autoimmunity and the direct cytotoxic effects of interferons on the myocardium may account for this uncommon adverse effect of interferon therapy.</p></div>\",\"PeriodicalId\":72741,\"journal\":{\"name\":\"Current problems in cancer. Case reports\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current problems in cancer. Case reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S266662192300039X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current problems in cancer. Case reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266662192300039X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
Reversible cardiomyopathy after interferon-gamma for cutaneous T cell lymphoma: A report of two cases
Interferons are widely expressed cytokines that possess potent anti-viral and anti-tumor activity. As therapeutic agents, interferons have proven useful in treating assorted cancers, chronic infections, and autoimmune disease. However, interferon therapy has well-known adverse effects, including flu-like symptoms, depression, triggering of autoimmune phenomena, and dose-dependent cytopenias. In this report, we describe two cases of congestive heart failure occurring after treatment with interferon-gamma (a type II interferon) for advanced cutaneous T cell lymphoma. Based on existing mechanistic studies, both the potentiation of autoimmunity and the direct cytotoxic effects of interferons on the myocardium may account for this uncommon adverse effect of interferon therapy.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
